{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["38(7)"],"submitter":["Ishimori S"],"pubmed_abstract":["<h4>Background</h4>Prospective research of children receiving heterogeneous vaccines has shown that immunization is not associated with pediatric idiopathic nephrotic syndrome (NS) relapses. However, prospective data concentrating only on influenza (flu) virus vaccines are not available.<h4>Methods</h4>This multicenter prospective study was conducted in children with NS who received inactivated flu vaccines from June 2017 to July 2018. The day of flu vaccination was defined as day 0, and the period between prevaccination and postvaccination days was defined as - X to + Y (period from day - 180 to 0 as the precontrolled period). The primary outcome was the NS relapse rate from day 0 to + 30 as a direct association with vaccination compared with those in the precontrolled period. Exacerbatio"],"journal":["Pediatric nephrology (Berlin, Germany)"],"pagination":["2107-2116"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9709736"],"repository":["biostudies-literature"],"pubmed_title":["Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study."],"pmcid":["PMC9709736"],"pubmed_authors":["Fujimura J","Horinouchi T","Nozu K","Sato M","Ishikura K","Ogura M","Ishimori S","Yamamura T","Kamiyoshi N","Kamei K","Iijima K","Matsunoshita N"],"additional_accession":[]},"is_claimable":false,"name":"Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study.","description":"<h4>Background</h4>Prospective research of children receiving heterogeneous vaccines has shown that immunization is not associated with pediatric idiopathic nephrotic syndrome (NS) relapses. However, prospective data concentrating only on influenza (flu) virus vaccines are not available.<h4>Methods</h4>This multicenter prospective study was conducted in children with NS who received inactivated flu vaccines from June 2017 to July 2018. The day of flu vaccination was defined as day 0, and the period between prevaccination and postvaccination days was defined as - X to + Y (period from day - 180 to 0 as the precontrolled period). The primary outcome was the NS relapse rate from day 0 to + 30 as a direct association with vaccination compared with those in the precontrolled period. Exacerbatio","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jul","modification":"2026-03-27T16:13:05.369Z","creation":"2025-04-19T14:42:15.166Z"},"accession":"S-EPMC9709736","cross_references":{"pubmed":["36449102"],"doi":["10.1007/s00467-022-05783-z"]}}